Literature DB >> 11509483

Impaired skin capillary recruitment in essential hypertension is caused by both functional and structural capillary rarefaction.

E H Serné1, R O Gans, J C ter Maaten, G J Tangelder, A J Donker, C D Stehouwer.   

Abstract

Capillary rarefaction occurs in many tissues in patients with essential hypertension and may contribute to an increased vascular resistance and impaired muscle metabolism. Rarefaction may be caused by a structural (anatomic) absence of capillaries, functional nonperfusion, or both. The aim of this study was to assess the extent of structural versus functional capillary rarefaction in the skin of subjects with essential hypertension. We examined skin capillary density with video microscopy before and during maximization of the number of perfused capillaries by venous congestion (structural capillary number) and before and during postocclusive reactive hyperemia (capillary recruitment, which may have a structural and/or functional basis). The study group was composed of 26 patients with never-treated essential hypertension and 26 normotensive control subjects. In both groups, intermittently perfused capillaries in the resting state were an important functional reserve for recruitment during postocclusive hyperemia. Recruitment of perfused capillaries during postocclusive reactive hyperemia was decreased in the hypertensive subjects compared with normotensive control subjects (47.9+/-6.8 versus 55.3+/-8.2 capillaries/mm(2), respectively; P<0.01). During venous occlusion, maximal capillary density was significantly lower in the hypertensive subjects than in the control subjects (52.5+/-6.6 versus 57.2+/-8.6 capillaries/mm(2), respectively; P<0.05), suggesting structural rarefaction. However, in the hypertensive subjects compared with the normotensive subjects, a smaller proportion of the maximal number of capillaries was perfused during postocclusive hyperemia (91.6+/-7.5% versus 97.2+/-2.7%, respectively; P<0.05), suggesting an additional functional impairment of capillary recruitment. If the difference in capillary numbers during venous congestion ( approximately 4.6 capillaries/mm(2)) truly reflects the structural difference between the normotensive and hypertensive subjects, then, at most, 62% (4.6/7.4x100%) of the difference in capillary numbers during postocclusive hyperemia ( approximately 7.4 capillaries/mm(2)) can be explained by structural defects, and at least 38% can be explained by functional defects. In conclusion, in patients with essential hypertension, recruitment of perfused capillaries is impaired, which can be explained by both functional and structural rarefaction.

Entities:  

Mesh:

Year:  2001        PMID: 11509483     DOI: 10.1161/01.hyp.38.2.238

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  60 in total

Review 1.  Microvascular rarefaction: the decline and fall of blood vessels.

Authors:  Michael S Goligorsky
Journal:  Organogenesis       Date:  2010 Jan-Mar       Impact factor: 2.500

2.  Alterations in capillary morphology are found in mild blood pressure elevation.

Authors:  Cynthia Cheng; Constantine Daskalakis; Bonita Falkner
Journal:  J Hypertens       Date:  2010-11       Impact factor: 4.844

3.  A Reproducible Computerized Method for Quantitation of Capillary Density using Nailfold Capillaroscopy.

Authors:  Cynthia Cheng; Chadd W Lee; Constantine Daskalakis
Journal:  J Vis Exp       Date:  2015-10-27       Impact factor: 1.355

Review 4.  Capillary rarefaction as an index for the microvascular assessment of hypertensive patients.

Authors:  Areti Triantafyllou; Panagiota Anyfanti; Athina Pyrpasopoulou; Georgios Triantafyllou; Spyros Aslanidis; Stella Douma
Journal:  Curr Hypertens Rep       Date:  2015-05       Impact factor: 5.369

5.  Functional capillary rarefaction in mild blood pressure elevation.

Authors:  Cynthia Cheng; James J Diamond; Bonita Falkner
Journal:  Clin Transl Sci       Date:  2008-05       Impact factor: 4.689

6.  Capillary Rarefaction Associates with Albuminuria: The Maastricht Study.

Authors:  Remy J H Martens; Ronald M A Henry; Alfons J H M Houben; Carla J H van der Kallen; Abraham A Kroon; Casper G Schalkwijk; Miranda T Schram; Simone J S Sep; Nicolaas C Schaper; Pieter C Dagnelie; Dennis M J Muris; Ed H B M Gronenschild; Frank M van der Sande; Karel M L Leunissen; Jeroen P Kooman; Coen D A Stehouwer
Journal:  J Am Soc Nephrol       Date:  2016-05-09       Impact factor: 10.121

7.  Blood pressure normalization via pharmacotherapy improves cutaneous microvascular function through NO-dependent and NO-independent mechanisms.

Authors:  Daniel H Craighead; Caroline J Smith; Lacy M Alexander
Journal:  Microcirculation       Date:  2017-10       Impact factor: 2.628

Review 8.  Assessing Microvascular Function in Humans from a Chronic Disease Perspective.

Authors:  Alfons J H M Houben; Remy J H Martens; Coen D A Stehouwer
Journal:  J Am Soc Nephrol       Date:  2017-09-13       Impact factor: 10.121

9.  Differential effects of nebivolol vs. metoprolol on microvascular function in hypertensive humans.

Authors:  Alejandro Velasco; Elizabeth Solow; Angela Price; Zhongyun Wang; Debbie Arbique; Gary Arbique; Beverley Adams-Huet; Edzard Schwedhelm; Jonathan R Lindner; Wanpen Vongpatanasin
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-05-13       Impact factor: 4.733

Review 10.  The macrocirculation and microcirculation of hypertension.

Authors:  François Feihl; Lucas Liaudet; Bernard Waeber
Journal:  Curr Hypertens Rep       Date:  2009-06       Impact factor: 5.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.